Sign up free

Lycia Therapeutics, Inc. (LYCA) insider trading

Lycia Therapeutics, Inc. insiders have made 2 open-market purchases worth $38.3M since Oct 27, 2026, by 1 insider. The latest: Bong Y. Koh (10% owner) bought $645k, filed Oct 30, 2026, scored 19 out of 100. The biggest: $37.7M by Bong Y. Koh, filed Oct 27, 2026.

Follow LYCA, freeOpen the live feed

A free account gets an alert the minute a new buy or sale is filed.

+$38.3Mnet insider buying, 90 days
+$38.3Mnet insider buying, 12 months
1 · 0insiders buying · selling, 12 months
19score of the latest buy, Oct 30

Insider purchases

FiledInsiderStakeScoreBought1 week1 month
Oct 30
Form 4 (opens sec.gov)
Bong Y. Koh10% owner10% owner +0% stake 19 $645k
25,004 at $25.78
waitingwaiting
Oct 27
Form 4 (opens sec.gov)
Bong Y. Koh10% owner10% owner +43% stake 36 $37.7M
2,045,440 at $18.41
waitingwaiting

Investors with more than 5% of LYCA (13D and 13G)

FiledInvestorKindStake
Oct 30
13G
Venrock Healthcare Capital Partners III, L.P.Passive11.9%

A 13D is filed by an investor who may push for change; a 13G by a passive one.

Insiders who bought LYCA

Questions

Are insiders buying LYCA stock?

Yes. In the last 90 days, 2 open-market purchases were filed, worth $38.3M.

Who bought LYCA stock most recently?

Bong Y. Koh, 10% owner, bought 25,004 shares for $645k (Form 4 (opens sec.gov), filed Oct 30, 2026).

How does InsiderBeacon score an insider buy?

Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.

Insiders are also buying, same industry

Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer

Follow insiders. Sell when they sell.Free in early access, no card

Sign up free